Antisense oligonucleotide therapy for TTR amyloidosis

被引：0
|
作者：
Benson, M. D. [1 ,2 ]
Pandey, S. [3 ]
Witchell, D. [3 ]
Jazayeri, A. [3 ]
Siwkowski, A. [3 ]
Monia, B. [3 ]
Kluve-Beckerman, B. [1 ]
机构：
[1] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA
[2] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA
[3] ISIS Pharmaceut, Carlsbad, CA 92008 USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
    Daniel R. Scoles
    Pratap Meera
    Matthew D. Schneider
    Sharan Paul
    Warunee Dansithong
    Karla P. Figueroa
    Gene Hung
    Frank Rigo
    C. Frank Bennett
    Thomas S. Otis
    Stefan M. Pulst
    Nature, 2017, 544 : 362 - 366
  • [42] Antisense oligonucleotide therapy for KCNT1 encephalopathy
    Burbano, Lisseth Estefania
    Li, Melody
    Jancovski, Nikola
    Jafar-Nejad, Paymaan
    Richards, Kay
    Sedo, Alicia
    Soriano, Armand
    Rollo, Ben
    Jia, Linghan
    V. Gazina, Elena
    Piltz, Sandra
    Adikusuma, Fatwa
    Thomas, Paul Q.
    Kopsidas, Helen
    Rigo, Frank
    Reid, Christopher A.
    Maljevic, Snezana
    Petrou, Steven
    JCI INSIGHT, 2022, 7 (23)
  • [43] Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
    Scoles, Daniel R.
    Meera, Pratap
    Schneider, Matthew D.
    Paul, Sharan
    Dansithong, Warunee
    Figueroa, Karla P.
    Hung, Gene
    Rigo, Frank
    Bennett, C. Frank
    Otis, Thomas S.
    Pulst, Stefan M.
    NATURE, 2017, 544 (7650) : 362 - +
  • [44] Transthyretin (TTR) Cardiac Amyloidosis
    Ruberg, Frederick L.
    Berk, John L.
    CIRCULATION, 2012, 126 (10) : 1286 - 1300
  • [45] Respirable Antisense Oligonucleotide (RASON) Therapy for Allergic Asthma
    W. James Metzger
    Jonathan W. Nyce
    BioDrugs, 1999, 12 : 237 - 243
  • [46] Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
    Nadine Attal
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [47] SERIAL MEASUREMENTS OF CIRCULATING TRANSTHYRETIN (TTR) IN SUBJECTS WITH TTR AMYLOIDOSIS OR CARRIERS OF MUTANT TTR
    Berk, J.
    Connors, L.
    Hankinson, E.
    Falzone, R.
    Figueroa, Y.
    Hutabarat, R.
    Butler, J.
    Kretschmer, M.
    Sah, D. W. Y.
    Cehelsky, J.
    Vaishnaw, A.
    Gollob, J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S10 - S11
  • [48] PHASE 1 INVESTIGATION OF A LIGAND-CONJUGATED ANTISENSE OLIGONUCLEOTIDE FOR THE TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS
    Viney, Nicholas
    Tai, Li-Jung
    Jung, Shiangtung
    Guthrie, Spencer
    Baker, Brenda
    Geary, Richard
    Schneider, Eugene
    Guo, Shuling
    Monia, Brett
    MUSCLE & NERVE, 2019, 60 : S64 - S64
  • [49] Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
    Viney, Nicholas J.
    Guo, Shuling
    Tai, Li-Jung
    Baker, Brenda F.
    Aghajan, Mariam
    Jung, Shiangtung W.
    Yu, Rosie Z.
    Booten, Sheri
    Murray, Heather
    Machemer, Todd
    Burel, Sebastien
    Murray, Sue
    Buchele, Gustavo
    Tsimikas, Sotirios
    Schneider, Eugene
    Geary, Richard S.
    Benson, Merrill D.
    Monia, Brett P.
    ESC HEART FAILURE, 2021, 8 (01): : 652 - 661
  • [50] Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis
    Kluve-Beckerman, Barbara
    Hardwick, Joyce
    Du, Lijing
    Benson, Merrill D.
    Monia, Brett P.
    Watt, Andrew
    Crooke, Rosanne M.
    Mullick, Adam
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 (03): : 136 - 146
12345